Publications by authors named "Zafeiris Zafeiriou"

32Publications

First trimester neutrophil to lymphocyte ratio (NLR) and pregnancy outcome.

J Obstet Gynaecol 2020 Jan 14;40(1):59-64. Epub 2019 Oct 14.

Third Department of Obstetrics and Gynaecology, "Attikon" Hospital, National and Kapodistrian University of Athens, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01443615.2019.1606171DOI Listing
January 2020

Genetic Analysis of Circulating Tumour Cells.

Recent Results Cancer Res 2020 ;215:57-76

The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-26439-0_3DOI Listing
October 2019

First trimester neutrophil-to-lymphocyte ratio (NLR) and pregnancy outcomes in medically assisted reproduction (MAR): a case control study.

Gynecol Endocrinol 2019 May 6;35(5):434-438. Epub 2019 Jan 6.

e First Department of Obstetrics and Gynaecology , Alexandra Hospital, Medical School, National and Kapodistrian University of Athens , Athens , Greece.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/09513590.2018.1
Publisher Site
http://dx.doi.org/10.1080/09513590.2018.1534949DOI Listing
May 2019

Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses.

Clin Genitourin Cancer 2016 12 5;14(6):485-493. Epub 2016 May 5.

Prostate Cancer Targeted Therapy Group and Drug Development Unit, The Royal Marsden National Health Services Foundation Trust and The Institute of Cancer Research, Sutton, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.04.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132155PMC
December 2016

Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents.

Drugs 2016 Mar;76(4):421-30

Division of Clinical Studies, The Institute of Cancer Research, Downs Rd, Sutton, London, Surrey, SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-015-0530-7DOI Listing
March 2016

CCR 20th Anniversary Commentary: Circulating Tumor Cells in Prostate Cancer.

Clin Cancer Res 2015 Nov;21(22):4992-5

Institute of Cancer Research and Royal Marsden Hospital, Sutton, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-3129DOI Listing
November 2015

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

N Engl J Med 2015 Oct;373(18):1697-708

From the Institute of Cancer Research (J.M., S.C., S.S., S.M., H.M., R.P.-L., D.N.R., A.O., N.T., G.B., N.P., P.F., A.G., I.F., C.P., G.S., D.B., J.G., Z.Z., C.T.W., R.F., R.R., B.E., G.F., D. Roda, W.Y., R.B., H.P., R.A., A.S., R.E., G.A., C.J.L., A.A., E.H., J.S.B.), the Royal Marsden NHS Foundation Trust (J.M., S.S., R.P.-L., A.O., N.T., D.B., Z.Z., R.F., D. Roda, R.E., G.A., J.S.B.), and University College London Hospital (U.M.), London, Queen's University, Belfast (S.J.), University of Leeds, Leeds (C.R.), Churchill Hospital, Oxford (A.P.), University of Liverpool, Liverpool (S.H.), Beatson West of Scotland Cancer Centre, Glasgow (R.J.), and Christie Hospital, Manchester (T.E.) - all in the United Kingdom; the University of Michigan, Ann Arbor (D. Robinson, Y.-M.W., X.C., L.P.K., F.Y.F., A.M.C.); Weill Cornell Medical College, New York (M.A.R.); and Thomas Jefferson University, Philadelphia (K.E.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1506859DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228595PMC
October 2015

Cabozantinib-Getting Under the Skin of Cutaneous Toxicity.

JAMA Oncol 2015 Jul;1(4):535-6

The Institute of Cancer Research, Royal Marsden Hospital, London, England.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.0702DOI Listing
July 2015

Integrative clinical genomics of advanced prostate cancer.

Cell 2015 May;161(5):1215-1228

Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2015.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484602PMC
May 2015

Switching and withdrawing hormonal agents for castration-resistant prostate cancer.

Nat Rev Urol 2015 Jan;12(1):37-47

Prostate Cancer Targeted Therapy Group, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2014.345DOI Listing
January 2015

Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer.

Mod Pathol 2013 Feb 31;26(2):302-13. Epub 2012 Aug 31.

Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Heraklion, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2012.150DOI Listing
February 2013